Kuehn Law Encourages Investors of Akero Therapeutics, Inc. to Contact Law Firm By Investing.com
NEW YORK, NY–(Newsfile Corp. – December 30, 2024) – Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors Akero Therapeutics, Inc. (NASDAQ: NASDAQ:) breached their fiduciary duties to shareholders. The investigation concerns potential self-employment. Shareholders may have rights to damages and corporate governance reforms. if you are long term … Read more